Folate deficiency modifies the risk of CIN3+ associated with DNA methylation levels: a nested case-control study from the ASCUS-COL trial

ABSTRACT: Purpose: To our knowledge, there are very few studies evaluating if the levels of folate modify the risk of cervical intraepithelial neoplasia grade 2 and higher (CIN2+ and CIN3+) associated with the levels of HPV genome methylation, two cofactors related to single carbon metabolism and in...

Full description

Autores:
Agudelo Fernández, María Cecilia
Agudelo Gamboa, Samuel
Ramírez Pineda, Arianis Tatiana
Castañeda Vanegas, Kelly Melisa
Garcés Palacio, Isabel Cristina
Sánchez Vásquez, Gloria
Lorincz, Attila
Zea, Arnold H.
Piyathilake, Chandrika
Tipo de recurso:
Article of investigation
Fecha de publicación:
2024
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/45268
Acceso en línea:
https://hdl.handle.net/10495/45268
Palabra clave:
Atypical Squamous Cells of the Cervix
Células Escamosas Atípicas del Cuello del Útero
Case-Control Studies
Estudios de Casos y Controles
DNA Methylation
Metilación de ADN
Folic Acid
Ácido Fólico
Folic Acid Deficiency
Deficiencia de Ácido Fólico
Uterine Cervical Dysplasia
Displasia del Cuello del Útero
https://id.nlm.nih.gov/mesh/D065309
https://id.nlm.nih.gov/mesh/D016022
https://id.nlm.nih.gov/mesh/D019175
https://id.nlm.nih.gov/mesh/D005492
https://id.nlm.nih.gov/mesh/D005494
https://id.nlm.nih.gov/mesh/D002578
Rights
openAccess
License
https://creativecommons.org/licenses/by/4.0/
Description
Summary:ABSTRACT: Purpose: To our knowledge, there are very few studies evaluating if the levels of folate modify the risk of cervical intraepithelial neoplasia grade 2 and higher (CIN2+ and CIN3+) associated with the levels of HPV genome methylation, two cofactors related to single carbon metabolism and independently associated with cervical cancer in previous studies. We conducted a case-control study nested in a three-arm randomized clinical pragmatic trial (ASCUS-COL trial) to evaluate the risk of CIN3+ associated with methylation levels according to serum folate concentrations. Methods: Cases (n = 155) were women with histologically confirmed CIN2+ (113 CIN2, 38 CIN3, and 4 SCC) and controls were age and follow-up time at diagnosis-matched women with histologically confirmed ≤ CIN1 (n = 155), selected from the 1122 hrHPV + women of this trial. The concentrations of serum folate were determined by the radioimmunoassay SimulTRAC-SNB-VitaminB12/Folate-RIAKit and the methylation levels by the S5 classifier. Stepwise logistic regression models were used to estimate the association between folate or methylation levels and CIN2+ or CIN3+. The joint effect of folate levels and methylation on the risk of CIN3+ was estimated using combinations of categorical stratifications. Results: Folate levels were significantly lower in women with CIN3+ than in other diagnostic groups (p = 0.019). The risk of CIN3+ was eight times higher (OR 8.9, 95% CI 3.4-24.9) in women with folate deficiency and high methylation levels than in women with normal folate and high methylation levels (OR 1.4, 95% CI 0.4-4.6). Conclusion: High methylation and deficient folate independently increased the risk of CIN3+ while deficient folate combined with high methylation was associated with a substantially elevated risk of CIN3+.